Pressure BioSciences merger partner Cannaworx to launch hemp immune boosting product in mid-July

Pressure BioSciences Inc (OTCQB:PBIO) announced Thursday that its pending merger partner Cannaworx Inc will launch a patented proprietary hemp immune booster supplement by mid-July. Once it hits the market, the company believes this product could be one of very few over-the-counter, FDA-registered hemp supplements products — if not the only one — that can claim to be an immune booster. The active ingredient in the Cannaworx immune booster is a patented, proprietary blend of 44 amino acid fragments from pepsin, the company said. The product, enhanced with hemp seed oil, increases the number of helper T cells in the body, which boosts immune response by enabling macrophage cells to kill and consume bacteria, viruses and other invaders. READ: Pressure BioSciences says Cannaworx in potential deal to acquire Five Leaf Labs in Louisiana "To further enhance the immune boosting effect, we added hemp seed oil (no THC) to our patented formulation,” Cannaworx President Bobby Ghalili said in a statement. “Hemp seed oil is rich in essential fatty acids (like omega-6 and omega-3) and antioxidants that may help fight inflammation, cancer, diabetes, and heart disease.  “Omega-3 is also thought to have a positive impact on the bowel microbiome as a prebiotic, providing further support to the immune system. The manufacturing process of the patented 44 amino acid fragment formulation is highly proprietary, protected, and would be nearly impossible to imitate." Ghalili plans to initially introduce the immune booster to the US market through the network of more than 50 sales representatives who are part of other pending acquisition Five Leaf Labs. “With this novel patented product, its unique immune boosting capabilities, its enhanced hemp seed oil addition and a strong sales and distribution network, we expect the upcoming launch of our immune booster to generate strong revenue immediately following its mid-July product launch,” Ghalili said. Pressure BioSciences, Cannaworx and SkinScience Labs Inc are set to merge and become Avaiia Bio. The combined business has an intellectual property estate of 31 issued and a dozen or more pending patents, as well as an existing global base of hundreds of corporate and thousands of retail customers. Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com Follow him on Twitter @andrew_kessel